However, unlike monogenic autoinflammatory diseases such as cryopyrin‐associated periodic syndrome (CAPS), a straightforward treatment such as IL‐1 blockade is not consistently effective for PSTPIP1‐associated conditions. This evidence concerns the gene PSTPIP1 and cryopyrin-associated periodic syndrome.